This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holroyde, C. P. Articles by Reichard, G. A. Search for Related Content PubMed PubMed Citation Articles by Holroyde, C. P. Articles by Reichard, G. A.

Lactate Metabolism in Patients with Metastatic Colorectal Cancer¹

Clinical Oncology Program and Department of Research, Lankenau Hospital, Philadelphia, Pennsylvania 19151

The possible effect of tumor glycolysis on whole-body lactate metabolism has not been previously measured in humans. Using an isotope tracer technique, we found increased rates of lactate production in 20 patients with metastatic colorectal cancer compared to 13 control subjects of comparable age and sex (15.6 ± 1.3 µmol/kg/min versus 10.4 ± 0.6 µmol/kg/min; p < 0.01). The cancer patients were characterized by a moderately increased rate of lactate oxidation (p < 0.05), a 2-fold increase in nonoxidative lactate disposal (p < 0.001), and an increased percentage of glucose derived from lactate (p < 0.01). There was a direct correlation between venous plasma lactate concentrations and lactate production rates. There was also a direct correlation between lactate production rates and the percentage of respiratory CO₂ derived from plasma lactate, the rates of lactate oxidation, the rates of nonoxidative lactate disposal, and the percentage of plasma glucose derived from plasma lactate. These observed results correlated poorly with tumor burden, and no correlation was observed between increased lactate production and the following clinical or biochemical parameters: ambulatory status, histological differentiation, weight change, carcinoembryonic antigen titer, hemoglobin, WBC, presence or absence of hepatic metastases, O₂ consumption, CO₂ production, respiratory quotient, plasma free fatty acids, glucose, and immunoreactive insulin concentrations. This study emphasizes that metabolic heterogeneity with respect to lactate metabolism exists within an apparently homogeneous group of patients with colorectal cancer.

¹ Supported in part by NIH Research Grants CA-20960 and AM-13527 and by Biomedical Research Support Grant 5-SO7-RR-05585-11.

² To whom requests for reprints should be addressed.

Received 4/12/79. Accepted 8/30/79.

This article has been cited by other articles:

				P. Rousseau Asthenia in terminally ill cancer patients: A brief review American Journal of Hospice and Palliative Medicine, September 1, 1997; 14(5): 258 - 261. [PDF]

				M. L. Goodstein, W. J. Richtsmeier, and L. A. Sauer The Effect of an Acute Fast on Human Head and Neck Carcinoma Xenograft: Growth Effects on an 'Isolated Tumor Vascular Pedicle' in the Nude Rat Arch Otolaryngol Head Neck Surg, August 1, 1993; 119(8): 897 - 902. [Abstract] [PDF]

				S. Edstrom, K. Bennegard, E. Eden, and K. Lundholm Energy and Tissue Metabolism in Patients With Cancer During Nutritional Support Arch Otolaryngol Head Neck Surg, November 1, 1982; 108(11): 697 - 699. [Abstract] [PDF]